These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17012519)

  • 1. Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder.
    Kahl KG; Greggersen W; Rudolf S; Stoeckelhuber BM; Bergmann-Koester CU; Dibbelt L; Schweiger U
    Psychosom Med; 2006; 68(5):669-74. PubMed ID: 17012519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder.
    Kahl KG; Rudolf S; Stoeckelhuber BM; Dibbelt L; Gehl HB; Markhof K; Hohagen F; Schweiger U
    Am J Psychiatry; 2005 Jan; 162(1):168-74. PubMed ID: 15625216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder.
    Kahl KG; Bester M; Greggersen W; Rudolf S; Dibbelt L; Stoeckelhuber BM; Gehl HB; Sipos V; Hohagen F; Schweiger U
    Psychosom Med; 2005; 67(3):407-12. PubMed ID: 15911903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa.
    Kahl KG; Rudolf S; Dibbelt L; Stoeckelhuber BM; Gehl HB; Hohagen F; Schweiger U
    Osteoporos Int; 2005 Apr; 16(4):424-9. PubMed ID: 15300363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder.
    Kahl KG; Bens S; Ziegler K; Rudolf S; Dibbelt L; Kordon A; Schweiger U
    Biol Psychiatry; 2006 Apr; 59(7):667-71. PubMed ID: 16199015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women.
    Zhao HY; Liu JM; Ning G; Zhao YJ; Zhang LZ; Sun LH; Xu MY; Uitterlinden AG; Chen JL
    Osteoporos Int; 2005 Dec; 16(12):1519-24. PubMed ID: 15782282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.
    Indridason OS; Franzson L; Sigurdsson G
    Osteoporos Int; 2005 Apr; 16(4):417-23. PubMed ID: 15776220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women.
    Mezquita-Raya P; de la Higuera M; García DF; Alonso G; Ruiz-Requena ME; de Dios Luna J; Escobar-Jiménez F; Muñoz-Torres M
    Osteoporos Int; 2005 Nov; 16(11):1368-74. PubMed ID: 15711777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major depression, borderline personality disorder, and visceral fat content in women.
    Greggersen W; Rudolf S; Fassbinder E; Dibbelt L; Stoeckelhuber BM; Hohagen F; Oltmanns KM; Kahl KG; Schweiger U
    Eur Arch Psychiatry Clin Neurosci; 2011 Dec; 261(8):551-7. PubMed ID: 21359599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
    Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
    HIV Med; 2005 May; 6(3):145-50. PubMed ID: 15876279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels.
    Pennisi P; Signorelli SS; Riccobene S; Celotta G; Di Pino L; La Malfa T; Fiore CE
    Osteoporos Int; 2004 May; 15(5):389-95. PubMed ID: 14661073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.
    Rogers A; Saleh G; Hannon RA; Greenfield D; Eastell R
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4470-5. PubMed ID: 12364420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin and bone mineral density in hemodiafiltration patients.
    Crisafulli A; Romeo A; Floccari F; Aloisi E; Atteritano M; Cincotta M; Aloisi C; Pizzoleo MA; Ruello A; Artemisia A; Valenti A; Frisina N; Teti D; Buemi M
    Ren Fail; 2005; 27(5):531-9. PubMed ID: 16152990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin and bone mass in squamous cell head and neck cancer patients.
    Valero C; Olmos JM; Rivera F; Hernández JL; Vega ME; Macías JG
    Calcif Tissue Int; 2006 Jun; 78(6):343-7. PubMed ID: 16830204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis.
    Grigorie D; Neacşu E; Marinescu M; Popa O
    Rom J Intern Med; 2003; 41(4):409-15. PubMed ID: 15526523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.
    Franck H; Meurer T; Hofbauer LC
    J Rheumatol; 2004 Nov; 31(11):2236-41. PubMed ID: 15517638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
    Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression.
    Atteritano M; Lasco A; Mazzaferro S; Macrì I; Catalano A; Santangelo A; Bagnato G; Bagnato G; Frisina N
    Intern Emerg Med; 2013 Sep; 8(6):485-91. PubMed ID: 21584846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet.
    Fiore CE; Pennisi P; Ferro G; Ximenes B; Privitelli L; Mangiafico RA; Santoro F; Parisi N; Lombardo T
    Horm Metab Res; 2006 Jun; 38(6):417-22. PubMed ID: 16823725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis.
    Vis M; Havaardsholm EA; Haugeberg G; Uhlig T; Voskuyl AE; van de Stadt RJ; Dijkmans BA; Woolf AD; Kvien TK; Lems WF
    Ann Rheum Dis; 2006 Nov; 65(11):1495-9. PubMed ID: 16606653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.